Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

I. Walraven; E. van 't Riet; C. D. A. Stehouwer; B. C. P. Polak; A. C. Moll; J. M. Dekker; G. Nijpels

doi:10.1007/s00125-013-2864-6

Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

I. Walraven^*, E. van 't Riet, C. D. A. Stehouwer, B. C. P. Polak, A. C. Moll, J. M. Dekker, G. Nijpels

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	1148-1154
Journal	Diabetologia
Volume	56
Issue number	5
DOIs	https://doi.org/10.1007/s00125-013-2864-6
Publication status	Published - May 2013

Keywords

Cancer
Cancer mortality
Epidemiology
Glucose metabolism
Proinsulin
Type 2 diabetes

Access to Document

10.1007/s00125-013-2864-6

Cite this

@article{7b7b1b713c0e458f9f520b9d00ad746b,

title = "Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study",

keywords = "Cancer, Cancer mortality, Epidemiology, Glucose metabolism, Proinsulin, Type 2 diabetes",

author = "I. Walraven and {van 't Riet}, E. and Stehouwer, {C. D. A.} and Polak, {B. C. P.} and Moll, {A. C.} and Dekker, {J. M.} and G. Nijpels",

year = "2013",

month = may,

doi = "10.1007/s00125-013-2864-6",

language = "English",

volume = "56",

pages = "1148--1154",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer, Cham",

number = "5",

}

TY - JOUR

T1 - Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

AU - Walraven, I.

AU - van 't Riet, E.

AU - Stehouwer, C. D. A.

AU - Polak, B. C. P.

AU - Moll, A. C.

AU - Dekker, J. M.

AU - Nijpels, G.

PY - 2013/5

Y1 - 2013/5

KW - Cancer

KW - Cancer mortality

KW - Epidemiology

KW - Glucose metabolism

KW - Proinsulin

KW - Type 2 diabetes

U2 - 10.1007/s00125-013-2864-6

DO - 10.1007/s00125-013-2864-6

M3 - Article

C2 - 23460020

VL - 56

SP - 1148

EP - 1154

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 5

ER -